19930 Federal Register / Vol. 72, No. 76 / Friday, April 20, 2007 / Notices 

Public Docket in Rm. S-4400, One 

Potomac Yard (South Bldg.), 2777 S. 

Crystal Drive, Arlington, VA. The hours 

of operation of this Docket Facility are 

from 8:30 a.m. to 4 p.m., Monday 

through Friday, excluding legal 

holidays. The Docket Facility telephone 

number is (703) 305–5805. 

2. Electronic access. You may access 

thisFederal Register document 

electronically through the EPA Internet 

under the ‘‘Federal Register’’ listings 

athttp://www.epa.gov/fedrgstr. 

A draft agenda has been developed 

and is posted on EPA’s web site 

at:http://www.epa.gov/pesticides/ppdc/. 

II. Background 

The Office of Pesticide Programs is 

entrusted with the responsibility to help 

ensure the safety of the American food 

supply, the education and protection 

from unreasonable risk of those who 

apply or are exposed to pesticides 

occupationally or through use of 

products, and general protection of the 

environment and special ecosystems 

from potential risks posed by pesticides. 

The Charter for EPA’s Pesticide 

Program Dialogue Committee (PPDC) 

was established under the Federal 

Advisory Committee Act (FACA), Public 

Law 92–463, in September 1995, and 

has been renewed every 2 years since 

that time. PPDC’s Charter was renewed 

November 5, 2005, for another 2–year 

period. The purpose of PPDC is to 

provide advice and recommendations to 

the EPA Administrator on issues 

associated with pesticide regulatory 

development and reform initiatives, 

evolving public policy and program 

implementation issues, and science 

issues associated with evaluating and 

reducing risks from use of pesticides. It 

is determined that PPDC is in the public 

interest in connection with the 

performance of duties imposed on the 

Agency by law. The following sectors 

are represented on the PPDC: Pesticide 

industry and trade associations; 

environmental/public interest, 

consumer, and animal rights groups; 

farm worker organizations; pesticide 

user, grower, and commodity groups; 

Federal and State/local/Tribal 

governments; the general public; 

academia; and public health 

organizations. 

Copies of the PPDC Charter are filed 

with appropriate committees of 

Congress and the Library of Congress 

and are available upon request. 

III. How Can I Request to Participate in 

this Meeting? 

PPDC meetings are open to the public 

and seating is available on a first-come 

basis. Persons interested in attending do 

not need to register in advance of the 

meeting. 

List of Subjects 

Environmental protection, 

Agriculture, Agricultural workers, 

Chemicals, Foods, Pesticides and pests, 

Public health. 

Dated: April 13, 2007. 

Marty Monell, 

Acting Director, Office of Pesticide Programs. 

[FR Doc. E7–7551 Filed 4–19–07; 8:45 am] 

BILLING CODE 6560–50–S 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisition of Shares of Bank or Bank 

Holding Companies 

The notificants listed below have 

applied under the Change in Bank 

Control Act (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire a bank or bank 

holding company. The factors that are 

considered in acting on the notices are 

set forth in paragraph 7 of the Act (12 

U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the office of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than May 7, 

2007. 

A. Federal Reserve Bank of Chicago 

(Burl Thornton, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690-1414: 

1. Randall R. Schwartz, Orland Park, 

Illinois; Susan M. Schwartz, Orland 

Park, Illinois; Richard H. Schwartz, 

Lemont, Illinois; Esther V. Schwartz, 

Lemont, Illinois; Clarence J. Ludwig, 

Sarasota, Florida; Mary Lou Ludwig, 

Sarasota, Florida; William D. Ludwig, 

Lincoln, Nebraska, Linda S. Macaskill, 

Sarasota, Florida; and John D. Macaskill, 

Sarasota, Florida; to retain at least 25 

percent of the voting shares of First 

Personal Financial Corp., Orland Park, 

Illinois, and thereby indirectly retain 

voting shares of First Personal Bank, 

Orland Park, Illinois. 

B. Federal Reserve Bank of Kansas 

City (Donna J. Ward, Assistant Vice 

President) 925 Grand Avenue, Kansas 

City, Missouri 64198-0001: 

1. Richard W. Willhour, Jr., Inola, 

Oklahoma; and Tommy L. Woods, 

Tulsa, Oklahoma, to individually 

control, and by Richard W. Willhour, Jr., 

Inola, Oklahoma; Tommy L. Woods, 

Thomas J. O’Brien, Matthew Q. 

Klimisch, and John R. Woolman, all of 

Tulsa, Oklahoma; Stephen M. Murphy 

and Curtis L. Roberts, both of Jenks, 

Oklahoma, all acting as a group in 

concert to acquire voting shares of 

CNBO Bancorp, Inc., Pryor, Oklahoma, 

and thereby indirectly acquire voting 

shares of Century National Bank of 

Oklahoma, Pryor, Oklahoma. 

Board of Governors of the Federal Reserve 

System, April 17, 2007. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. E7–7538 Filed 4–19–07; 8:45 am] 

BILLING CODE 6210–01–S 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR Part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The application also will be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Additional information on all bank 

holding companies may be obtained 

from the National Information Center 

Web site at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than May 17, 2007. 

A. Federal Reserve Bank of Atlanta 

(David Tatum, Vice President) 1000 

Peachtree Street, NE., Atlanta, Georgia 

30309: 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 72, No. 76 / Friday, April 20, 2007 / Notices 19931 

1The comment must be accompanied by an 

explicit request for confidential treatment, 

including the factual and legal basis for the request, 

and must identify the specific portions of the 

comment to be withheld from the public record. 

The request will be granted or denied by the 

Commission’s General Counsel, consistent with 

applicable law and the public interest. See 

Commission Rule 4.9(c), 16 CFR 4.9(c). 

1. Palm Bancorp, Inc., Tampa, 

Florida; to become a bank holding 

company by acquiring 100 percent of 

the voting shares of The Palm Bank, 

Tampa, Florida. 

B. Federal Reserve Bank of 

Minneapolis (Jacqueline G. King, 

Community Affairs Officer) 90 

Hennepin Avenue, Minneapolis, 

Minnesota 55480-0291: 

1. First American Investment, Inc., 

Lake Elmo, Minnesota; to become a 

bank holding company by acquiring 100 

percent of the voting shares of First 

American Bank, National Association, 

Hudson, Wisconsin (in organization). 

Board of Governors of the Federal Reserve 

System, April 17, 2007. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. E7–7537 Filed 4–19–07; 8:45 am] 

BILLING CODE 6210–01–S 

FEDERAL TRADE COMMISSION 

[File No. 071 0063] 

Actavis Group hf. and Abrika 

Pharmaceuticals, Inc.; Analysis of 

Agreement Containing Consent Order 

To Aid Public Comment 

AGENCY: Federal Trade Commission. 

ACTION: Proposed Consent Agreement. 

SUMMARY: The consent agreement in this 

matter settles alleged violations of 

federal law prohibiting unfair or 

deceptive acts or practices or unfair 

methods of competition. The attached 

Analysis To Aid Public Comment 

describes both the allegations in the 

draft complaint and the terms of the 

consent order—embodied in the consent 

agreement—that would settle these 

allegations. 

DATES: Comments must be received on 

or before May 14, 2007. 

ADDRESSES: Interested parties are 

invited to submit written comments. 

Comments should refer to ‘‘Actavis 

Group, et al., File No. 071 0063,’’ to 

facilitate the organization of comments. 

A comment filed in paper form should 

include this reference both in the text 

and on the envelope, and should be 

mailed or delivered to the following 

address: Federal Trade Commission/ 

Office of the Secretary, Room 135–H, 

600 Pennsylvania Avenue, NW., 

Washington, DC 20580. Comments 

containing confidential material must be 

filed in paper form, must be clearly 

labeled ‘‘Confidential,’’ and must 

comply with Commission Rule 4.9(c). 

16 CFR 4.9(c) (2005).1 The FTC is 

requesting that any comment filed in 

paper form be sent by courier or 

overnight service, if possible, because 

U.S. postal mail in the Washington area 

and at the Commission is subject to 

delay due to heightened security 

precautions. Comments that do not 

contain any nonpublic information may 

instead be filed in electronic form as 

part of or as an attachment to email 

messages directed to the following email box: consentagreement@ftc.gov. 

The FTC Act and other laws the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. All timely and responsive 

public comments, whether filed in 

paper or electronic form, will be 

considered by the Commission, and will 

be available to the public on the FTC 

Web site, to the extent practicable, at 

http://www.ftc.gov. As a matter of 

discretion, the FTC makes every effort to 

remove home contact information for 

individuals from the public comments it 

receives before placing those comments 

on the FTC Web site. More information, 

including routine uses permitted by the 

Privacy Act, may be found in the FTC’s 

privacy policy, at http://www.ftc.gov/ 

ftc/privacy.htm. 

FOR FURTHER INFORMATION CONTACT: Kari 

Wallace, (202) 326–3085, Bureau of 

Competition, Room NJ–5108, 600 

Pennsylvania Avenue, NW., 

Washington, DC 20580. 

SUPPLEMENTARY INFORMATION: Pursuant 

to section 6(f) of the Federal Trade 

Commission Act, 38 Stat. 721, 15 U.S.C. 

46(f), and § 2.34 of the Commission 

Rules of Practice, 16 CFR 2.34, notice is 

hereby given that the above-captioned 

consent agreement containing a consent 

order to cease and desist, having been 

filed with and accepted, subject to final 

approval, by the Commission, has been 

placed on the public record for a period 

of thirty (30) days. The following 

Analysis To Aid Public Comment 

describes the terms of the consent 

agreement, and the allegations in the 

complaint. An electronic copy of the 

full text of the consent agreement 

package can be obtained from the FTC 

Home Page (for April 16, 2007), on the 

World Wide Web, at http://www.ftc.gov/ 

os/2007/04/index.htm. A paper copy 

can be obtained from the FTC Public 

Reference Room, Room 130–H, 600 

Pennsylvania Avenue, NW., 

Washington, DC 20580, either in person 

or by calling (202) 326–2222. 

Public comments are invited, and may 

be filed with the Commission in either 

paper or electronic form. All comments 

should be filed as prescribed in the 

ADDRESSES section above, and must be 

received on or before the date specified 

in the DATES section. 

Analysis of Agreement Containing 

Consent Order To Aid Public Comment 

The Federal Trade Commission 

(‘‘Commission’’) has accepted, subject to 

final approval, an Agreement 

Containing Consent Order (‘‘Consent 

Agreement’’) from Actavis Group hf. 

(‘‘Actavis’’), which is designed to 

remedy the anticompetitive effects of 

the acquisition of Abrika 

Pharmaceuticals, Inc. (‘‘Abrika’’) by 

Actavis. Under the terms of the 

proposed Consent Agreement, the 

company would be required to assign 

and divest the Abrika rights and assets 

necessary to manufacture and market 

generic isradipine capsules to Cobalt 

Laboratories, Inc. (‘‘Cobalt’’), the U.S. 

subsidiary of Arrow Group. 

The proposed Consent Agreement has 

been placed on the public record for 

thirty (30) days for receipt of comments 

by interested persons. Comments 

received during this period will become 

part of the public record. After thirty 

(30) days, the Commission will again 

review the proposed Consent Agreement 

and the comments received, and will 

decide whether it should withdraw from 

the proposed Consent Agreement, 

modify it, or make final the Decision 

and Order (‘‘Order’’). 

Pursuant to an Agreement and Plan of 

Merger executed on November 20, 2006, 

Actavis proposes to acquire all of the 

voting securities of Abrika for $235 

million. The Commission’s Complaint 

alleges that the proposed acquisition, if 

consummated, would violate Section 7 

of the Clayton Act, as amended, 15 

U.S.C. 18, and Section 5 of the Federal 

Trade Commission Act, as amended, 15 

U.S.C. 45, by lessening competition in 

the U.S. markets for the manufacture 

and sale of generic isradipine capsules. 

The proposed Consent Agreement will 

remedy the alleged violation by 

replacing the lost competition that 

would result from the acquisition in this 

market. 

Actavis is a leading developer, 

manufacturer, marketer, and distributor 

of generic pharmaceutical drugs. 

Headquartered in Iceland, Actavis sells 

generic pharmaceuticals in over 30 

countries and has manufacturing 

facilities in Europe, the United States, 


sroberts on PROD1PC70 with NOTICES